Literature DB >> 2874329

T lymphocytes of rheumatoid arthritis patients show augmented reactivity to a fraction of mycobacteria cross-reactive with cartilage.

J Holoshitz, A Klajman, I Drucker, Z Lapidot, A Yaretzky, A Frenkel, W van Eden, I R Cohen.   

Abstract

An acetone-precipitable fraction of Mycobacterium tuberculosis cross-reacts with human cartilage. Immune responses to this antigen were assessed in 34 patients with rheumatoid arthritis, 16 patients with degenerative joint disease, and 15 healthy controls. The RA patients differed from the other two groups in having more pronounced T lymphocyte responses to the antigen; their serum antibody levels were not higher. The responses of RA patients varied with duration of disease. In the first year (7 patients) T lymphocyte reactivity was increased in the synovial exudates of affected joints but not in peripheral blood, whereas the 19 with disease of 1-10 years' duration showed high reactivity in peripheral blood; in the 8 with disease for more than 10 years, lymphocyte reactivity did not differ from that in the patients with degenerative joint disease or the healthy controls. The observation that the three groups did not differ in their responses to streptococci and a T-cell mitogen indicates that reactivity of the RA patients to the mycobacterial fraction was specific. These results raise the possibility that bacterial antigens cross-reactive with cartilage proteoglycans may be relevant to the pathogenesis of RA.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2874329     DOI: 10.1016/s0140-6736(86)90003-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  81 in total

1.  Poncet's disease: tuberculous rheumatism.

Authors:  M K Chaudhuri; S Singh; L Kumar
Journal:  Indian J Pediatr       Date:  1995 May-Jun       Impact factor: 1.967

2.  Anti-heat shock protein 70 kDa and 90 kDa antibodies in serum of patients with rheumatoid arthritis.

Authors:  G Hayem; M De Bandt; E Palazzo; S Roux; B Combe; J F Eliaou; J Sany; M F Kahn; O Meyer
Journal:  Ann Rheum Dis       Date:  1999-05       Impact factor: 19.103

3.  Dual antigenic recognition by cloned human gamma delta T cells.

Authors:  J Holoshitz; L M Vila; B J Keroack; D R McKinley; N K Bayne
Journal:  J Clin Invest       Date:  1992-01       Impact factor: 14.808

Review 4.  T cell regulation in autoimmune arthritis: possibilities for immunological intervention.

Authors:  W van Eden
Journal:  Immunol Res       Date:  1990       Impact factor: 2.829

Review 5.  Possibilities for the immunotherapy of rheumatoid arthritis.

Authors:  F C Breedveld; R R De Vries
Journal:  Clin Rheumatol       Date:  1990-06       Impact factor: 2.980

Review 6.  Immunotherapy through the IL-2 receptor.

Authors:  H A Verheul; M Verveld; E S Bos
Journal:  Immunol Res       Date:  1992       Impact factor: 2.829

7.  Heat-shock proteins and immunopathology: regulatory role of heat-shock protein-specific T cells.

Authors:  K Nomoto; Y Yoshikai
Journal:  Springer Semin Immunopathol       Date:  1991

8.  HLA-DR-associated isotype-specific regulation of antibody levels to mycobacteria in rheumatoid arthritis.

Authors:  G M Bahr; G A Rook; A Shahin; J L Stanford; M I Sattar; K Behbehani
Journal:  Clin Exp Immunol       Date:  1988-04       Impact factor: 4.330

9.  Experimental immune mediated arthritis in rhesus monkeys. A model for human rheumatoid arthritis?

Authors:  N P Bakker; M G van Erck; C Zurcher; P Faaber; A Lemmens; M Hazenberg; R E Bontrop; M Jonker
Journal:  Rheumatol Int       Date:  1990       Impact factor: 2.631

10.  Lack of T cell oligoclonality in enzyme-digested synovial tissue and in synovial fluid in most patients with rheumatoid arthritis.

Authors:  J M Van Laar; A M Miltenburg; M J Verdonk; M R Daha; R R De Vries; P J Van den Elsen; F C Breedveld
Journal:  Clin Exp Immunol       Date:  1991-03       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.